Laparoscopic Heller Myotomy versus Endoscopic Balloon Dilatation for the treatment of achalasia: A network meta-analysis

Annals of Surgery

Volumn 258, Issue 6, 2013, Pages 943-952

  Schoenberg, Markus B ^a,b   Marx, Svetlana ^d   Kersten, Jan F ^b   Rösch, Thomas ^e   Belle, Sebastian ^c   Kähler, Georg ^b   Vassiliou, Melina C ^f   Lüth, Stefan ^e   Von Renteln, Daniel ^e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Central Interdisciplinary Endoscopy ^*  (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

achalasia; economic cost; endoscopy; esophagus; health; idiopathic achalasia; laparoscopic surgery; meta analysis; motility disorders; network meta analysis; review; surgery

Indexed keywords

ANTIREFLUX OPERATION; ARTICLE; BALLOON DILATATION; CARDIOESOPHAGOMYOTOMY; ENDOSCOPIC SURGERY; ESOPHAGUS ACHALASIA; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; RETREATMENT; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DILATATION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGOSCOPY; HUMANS; LAPAROSCOPY; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888117365     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000212     Document Type: Article

References (47)

1. Triadafilopoulos G, Boeckxstaens GE, Gullo R, et al. The Kagoshima consensus on esophageal achalasia. Dis Esophagus. 2012;25:337-348.
2. Francis DL, Katzka DA. Achalasia: update on the disease and its treatment. Gastroenterology. 2010;139:369-374.
3. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249: 45-57.
4. Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci. 2009;54:2303-2311.
5. Ghoshal UC, Chaudhuri S, Pal BB, et al. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus. 2001;14:227-231.
6. Bansal R, Nostrant TT, Scheiman JM, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol. 2003;36:209-214.
7. Heller E. Extramuk̈ose Kardiaplastik beim chronischen Kardiospasmus mit Dilatation des Ö sophagus. Mitt Grenzgeb Med Chir. 1914;27:141-149.
8. Shimi S, Nathanson LK, Cuschieri A. Laparoscopic cardiomyotomy for achalasia. J R Coll Surg Edinb. 1991;36:152-154.
9. Rebecchi F, Giaccone C, Farinella E, et al. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann Surg. 2008;248: 1023-1030.
10. Kostic S, Kjellin A, Ruth M, et al. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg. 2007;31:470-478.
11. Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011;364:1807-1816.
12. Booth A, Clarke M, Ghersi D, et al. An international registry of systematicreview protocols. Lancet. 2011;377:108-109.
13. Schottker B, Luhmann D, Boulkhemair D, et al. Indirect comparisons of therapeutic interventions. GMS Health Technol Assess. 2009;5:Doc09.
14. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196.
15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
16. Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338:b1147.
17. Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9:1-134, iii-iv.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17: 1-12.
19. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical. Stat Med. 1989;8:441-454.
20. Miller JN, Colditz GA, Mosteller F. How study design affects outcomes in comparisons of therapy. II: Surgical. Stat Med. 1989;8:455-466.
21. Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472.
22. Song F, Glenny AM, Altman DG. Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Control Clin Trials. 2000;21:488-497.
23. Gamer M, Lemon J, Fellows I, Singh P. Various coefficients of interrater reliability and agreement (Version 0.83) [software] 2010. Available at: http://CRAN.R-project.org/package=irr.
24. R Development Core Team. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
25. Csendes A, Braghetto I, Henriquez A, et al. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut. 1989;30:299-304.
26. Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001;15:1389-1396.
27. Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44: 231-239.
28. Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg. 2004;239:364-370.
29. Zhu Q, Liu J, Yang C. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia. Dig Surg. 2009;26:493-498.
30. Allescher HD, StorrM, Seige M, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy. 2001;33:1007-1017.
31. Annese V, Basciani M, Perri F, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia.Gastroenterology. 1996;111:1418-1424.
32. Prakash C, Freedland KE, ChanMF, et al. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94:328-333.
33. Gockel I, Junginger T, Bernhard G, et al. Heller myotomy for failed pneumatic dilation in achalasia: how effective is it? Ann Surg. 2004;239:371-377.
34. Collard JM, Romagnoli R, Lengele B, et al. Heller-Dor procedure for achalasia: from conventional to video-endoscopic surgery. Acta Chir Belg. 1996;96: 62-65.
35. Douard R, Gaudric M, Chaussade S, et al. Functional results after laparoscopic Heller myotomy for achalasia: a comparative study to open surgery. Surgery. 2004;136:16-24.
36. Muehldorfer SM, Schneider TH, Hochberger J, et al. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation. Endoscopy. 1999;31:517-521.
37. Smith CD, Stival A, Howell DL, et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg. 2006;243:579-584; discussion 84-86.
38. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373:911-918.
39. Dughera L, Battaglia E, Maggio D, et al. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study. Drugs Aging. 2005;22:779-783.
40. Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60:869-876.
41. Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103:27-37.
42. Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135:1526-1533.
43. Pratap N, Reddy DN. Can achalasia subtyping by high-resolution manometry predict the therapeutic outcome of pneumatic balloon dilatation? Author's reply. J Neurogastroenterol Motil. 2011;17:205.
44. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265-271.
45. von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012;107:411-417.
46. Karanicolas PJ, Smith SE, Inculet RI, et al. The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia. Surg Endosc. 2007;21:1198-1206.
47. Kostic S, Johnsson E, Kjellin A, et al. Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy. Surg Endosc. 2007;21:1184-1189.